COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II)
Chronic infectious-immune myocarditis of severe course can potentially be considered as a factor that aggravates the course of new coronavirus disease (COVID-19) and increases the risk of adverse outcomes. The interaction of chronic myocarditis and COVID-19 during long-term immunosuppressive therapy...
| मुख्य लेखकों: | , , , , , , |
|---|---|
| स्वरूप: | लेख |
| भाषा: | English |
| प्रकाशित: |
Столичная издательская компания
2020-11-01
|
| श्रृंखला: | Рациональная фармакотерапия в кардиологии |
| विषय: | |
| ऑनलाइन पहुंच: | https://www.rpcardio.online/jour/article/view/2286 |